Author

Hyunjoo Kim

Institution: ABL Bio (South Korea)

Observed institution: ABL Bio (South Korea)

ORCID: 0009-0000-2730-4184

Observed ORCID: 0009-0000-2730-4184

OpenAlex ID: A5102914237

Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

2024 · Seung Hyuck Jeon, Gihoon You, et al. · Clinical Cancer Research · 17

Data from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

2024 · Seung Hyuck Jeon, Gihoon You, et al. · 1

Supplementary Figures S1-7 from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

2024 · Seung Hyuck Jeon, Gihoon You, et al.

Supplementary Tables 1-3 from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

2024 · Seung Hyuck Jeon, Gihoon You, et al.

Data from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

2024 · Seung Hyuck Jeon, Gihoon You, et al.

Supplementary Tables 4-7 from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

2024 · Seung Hyuck Jeon, Gihoon You, et al.

Supplementary Tables 4-7 from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade

2024 · Seung Hyuck Jeon, Gihoon You, et al.

Works count: 7

Citation count: 18

H-index: 1

I10-index: 1